PharmaInformatic´s Scientific Network

    We have a strong background  in ChemInformatics and BioInformatics, together with expertise in Information Technology and Artificial Intelligence (AI):

Rational Drug Design
Chemical Databases
Novel Descriptors
Molecular Modeling
Rule Based Docking
Chemical Similarity
Pharmacology & ADMET

3D Protein Structures
Sequence Analysis
Disease & Target-Databases
Protein Function & Interaction
Pharmacogenomics & SNPs
Enzymes & Metabolism

Data Preparation
Data Integration
Relational Databases
Object-Orientated Databases
Database Management
PACT-F

Prediction & Optimisation
Neural Networks
Decision Trees
Bayesian Learning
Data Mining & Text Mining
IMPACT-F


The largest  knowledge base
on bioavailability worldwide.
 


An expert system
to predict oral bioavailability
 in humans.


An expert system for finding
suitable
drug candidates.

 


 An expert system for finding molecules with antibiotic activity.
 


 An expert system for finding molecules with antiviral activity.
 

    Founder and CEO of PharmaInformatic is Dr W. Boomgaarden. He has developed virtual screening and drug design software products which have been successfully used in the pharmaceutical world. Before he founded the company, he worked as a professor in bioInformatics in Emden, Germany.

© Copyright 2004-2017 PharmaInformatic Boomgaarden. All rights reserved.         Site map         Contact         Terms of Use         Imprint        


Evaluate
efficiency of drugs
before
advanced clinical trials:
==>
IMPACT-F
BIOAVAILABILITY
ESTIMATION
(more)
 


Follow us on Twitter, connect via LinkedIn: